A detailed history of Genus Capital Management Inc. transactions in Amgen Inc stock. As of the latest transaction made, Genus Capital Management Inc. holds 23,195 shares of AMGN stock, worth $7.25 Million. This represents 0.86% of its overall portfolio holdings.

Number of Shares
23,195
Previous 20,395 13.73%
Holding current value
$7.25 Million
Previous $5.87 Billion 12.27%
% of portfolio
0.86%
Previous 0.86%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

BUY
$268.87 - $324.56 $6.24 Million - $7.53 Million
23,195 New
23,195 $6.59 Billion
Q2 2023

Aug 11, 2023

BUY
$214.27 - $253.37 $616,883 - $729,452
2,879 New
2,879 $639 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $167B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Genus Capital Management Inc. Portfolio

Follow Genus Capital Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Genus Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Genus Capital Management Inc. with notifications on news.